Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arimoclomol Citrate [mi]
2. 368860-21-3
3. Arimoclomol Citrate [usan]
4. Unii-q85ffy6179
5. Q85ffy6179
6. Orphazyme A/s
7. 3-pyridinecarboximidoyl Chloride, N-((2r)-2-hydroxy-3-(1-piperidinyl)propoxy)-, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
8. Arimoclomol Citrate (usan)
9. N-[(2r)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl Chloride;2-hydroxypropane-1,2,3-tricarboxylic Acid
10. N-((2r)-2-hydroxy-3-(1-piperidyl)propoxy)pyridine-3-carboximidoyl Chloride, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate
11. N-[(2r)-2-hydroxy-3-(1-piperidyl)propoxy]pyridine-3-carboximidoyl Chloride, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate
12. Schembl2681096
13. Da-61204
14. Q27287107
15. 855-142-3
16. Arimoclomol Citrate; 3-pyridinecarboximidoyl Chloride, N-[(2r)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 3-pyridinecarboximidoyl Chloride, N-[(2r)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide, 2-hydroxy-1,2,3-propanetricarbox
1. Arimoclomol
Molecular Weight | 505.9 g/mol |
---|---|
Molecular Formula | C20H28ClN3O10 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 11 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 203 |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 565 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Covalently Bonded Unit Count | 2 |
Treatment of amyotrophic lateral sclerosis
Treatment of amyotrophic lateral sclerosis, Treatment of sporadic inclusion body myositis
Treatment of Niemann-Pick disease, type C
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
30
PharmaCompass offers a list of Arimoclomol Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arimoclomol Citrate manufacturer or Arimoclomol Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arimoclomol Citrate manufacturer or Arimoclomol Citrate supplier.
PharmaCompass also assists you with knowing the Arimoclomol Citrate API Price utilized in the formulation of products. Arimoclomol Citrate API Price is not always fixed or binding as the Arimoclomol Citrate Price is obtained through a variety of data sources. The Arimoclomol Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Arimoclomol Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arimoclomol Citrate, including repackagers and relabelers. The FDA regulates Arimoclomol Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arimoclomol Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arimoclomol Citrate supplier is an individual or a company that provides Arimoclomol Citrate active pharmaceutical ingredient (API) or Arimoclomol Citrate finished formulations upon request. The Arimoclomol Citrate suppliers may include Arimoclomol Citrate API manufacturers, exporters, distributors and traders.
Arimoclomol Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Arimoclomol Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arimoclomol Citrate GMP manufacturer or Arimoclomol Citrate GMP API supplier for your needs.
A Arimoclomol Citrate CoA (Certificate of Analysis) is a formal document that attests to Arimoclomol Citrate's compliance with Arimoclomol Citrate specifications and serves as a tool for batch-level quality control.
Arimoclomol Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Arimoclomol Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Arimoclomol Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Arimoclomol Citrate EP), Arimoclomol Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arimoclomol Citrate USP).